← FDA Drug Approvals (Drugs@FDA)

VYVANSE

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2007-02-23

Drug application

FDA Application #

NDA021977

Application type

New Drug Application

Brand name

VYVANSE

Generic name

LISDEXAMFETAMINE DIMESYLATE

Active ingredients

LISDEXAMFETAMINE DIMESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2007-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown